Dear colleague,

This is your last chance to book at the lowest rate and join Carl June, Crystal Mackall, Peter Emtage, 60+ speakers and 350+ attendees at the Onco Cell Therapy Summit on April 7-8 2020, in Boston.

We are launching our largest event yet, with four tracks focus on CAR-T R&D, Alternative Cell Therapies, Vein-to-Vein manufacturing, and Commercialization, Regulation and Safety.

You can access the full, two day, 4 track, 60 speaker agenda here.

What key takeaways that you can expect from the 2020 summit?

• Iovance Biotherapeutics’ CMO, Friedrich Graf Finckenstein delves into the development of autologous cellular immunotherapies optimizing personalized tumor directed TILs
• Assess cell therapy manufacturing models to transition from outsourcing to in-house manufacturing facilities with Mustang Bio’s CTO, Knut Niss
• Hear the FDA’s advice on best practice for REMS development for improved pre-market approval rates
• Target solid tumors using CAR-T cells secreting BiTEs to circumvent antigen escape with Bryan Choi, MGH

Click here to book at the lowest price until January 24.

We hope to see you in Boston to revolutionize patient outcomes in cancer therapies.

Best wishes,
Fred Metherell
Event Producer